Shopping Cart
- Remove All
- Your shopping cart is currently empty
NBI-6024, an altered peptide ligand (APL), acts as an epitope for interferon-gamma-producing T helper lymphocytes linked to inflammation in type 1 diabetes patients [1] [2].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | 8-10 weeks | |
50 mg | Inquiry | 8-10 weeks |
Description | NBI-6024, an altered peptide ligand (APL), acts as an epitope for interferon-gamma-producing T helper lymphocytes linked to inflammation in type 1 diabetes patients [1] [2]. |
In vivo | NBI-6024, administered subcutaneously at doses ranging from 0.005 to 20 mg/kg, slows the progression and decreases the occurrence of diabetes in mice [2]. |
Molecular Weight | 1521.72 |
Formula | C66H112N20O21 |
Cas No. | 239480-61-6 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.